Woodline Partners »

Celldex Therapeutics shares owned by Woodline Partners

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $80M 2.3M 33.99
2024-06-30 $28M 758k 37.01
2024-03-31 $32M 751k 41.97
2023-09-30 $3.0M 108k 27.52
2023-06-30 $1.8M 55k 33.93
2023-03-31 $2.0M 56k 35.98
2022-06-30 $1.7M 65k 26.97
2022-03-31 $20M 579k 34.06
2021-12-31 $10M 260k 38.64